Search Results 51-60 of 33524 for Two-phase

  1. Mayo Clinic Q and A: Dysphagia is a common concern with several possible explanations

    There are two phases of swallowing. The first is the oropharyngeal phase. It involves the mouth and throat. The second is the esophageal phase. It involves ...

  2. Mayo Clinic Diet named Best Commercial Diet by U.S. News & World Report

    This phase is designed to help dieters continue to lose 1 to 2 pounds each week until they reach their desired healthy weight and sustain it. MEDIA CONTACT: ...

  3. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior systemic treatment for ...

  4. A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF - Mayo Clinic

    This phase 2 clinical study will be a randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, biological activity, ...

  5. Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis - Mayo Clinic

    This trial consists of two phases: 16 weeks of double-blind treatment and 24 weeks of open-label extension. Participation eligibility. Participant ...

  6. Mayo Clinic Comprehensive Cancer Center — Research

    Scottsdale/Phoenix, Ariz. This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate ...

  7. Phase 2 Study of TAK-341 for Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas - Mayo Clinic

    Clinical Trials · A Phase 1/​2 Study of STP938 for Adult Subjects With Relapsed/​Refractory B-Cell and T-Cell Lymphomas · More about research at Mayo Clinic · Mayo ...

  9. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) · Share · Facebook · Twitter.

  10. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the safety and ...